ABLE TO CURE, ABLE TO PAY- CLOSING THE WIDENING GAP
Author(s)
Moderator: Robert W. Dubois, MD, PhD, Chief Science Officer, National Pharmaceutical Council, Washington, DC, USA
Speakers: Alexander Billioux, MD, Assistant Secretary of Health, Louisiana Department of Health's Office of Public Health, Baton Rouge, LA, USA; Vadim Lubarsky, MBA, Executive Director, CMS Policy and Reimbursement, US Public Policy, Novartis Services, Inc., Washington, DC, USA
Presentation Documents
Innovative and potentially curative therapies for life-threatening cancers and genetic disorders are becoming available now, and many more are in the pipeline. These new therapies will be transformative for patients facing serious illness—but the science is getting ahead of the health care system, which is not prepared to sustain the costs associated with them. During this session, panelists will explore the leading edge approaches that are being considered and/or implemented such as Netflix-style subscription payments and annuity payments, and debate the challenges to closing the widening gap between our ability to cure and our ability to pay.
Conference/Value in Health Info
2019-05, ISPOR 2019, New Orleans, LA, USA